Skip to main content
NCBI home page
Cancer Biomarkers: Section A of Disease Markers logoLink to Cancer Biomarkers: Section A of Disease Markers
. 2016 Apr 13;16(4):523–528. doi: 10.3233/CBM-160593

Pretreatment neutrophil-lymphocyte count ratio may associate with gastric cancer presence

Yuanyuan Jiang a, Huan Xu b, Hongmin Jiang a,*, Siyi Ding a, Taiqing Zheng a
PMCID: PMC13016513  PMID: 27062567

Abstract

BACKGROUND:

Inflammation plays a pivotal role in cancer development and progression. Neutrophil-lymphocyte count ratio (NLR) is an indicator of systemic inflammatory response which is supposedly associated with gastric cancer (GC) development and progression. Since this parameter can be easily obtained from routine blood examination, it will be a great economic relief to gastric patients if we can bring it into clinical application.

OBJECTIVE:

The current study aims to evaluate the pretreatment NLR in gastric cancer patients through retrospectively reviewing the medical records.

METHODS:

A total of 327 patients hospitalized on a tertiary care hospital were retrospectively investigated and divided into two groups. Gastric cancer group were composed of patients with newly diagnosed, pathologically confirmed GC and the control group were patients with gastric polyp or benign gastric stromal tumor. The value of NLR in the presence and stage of gastric cancer was investigated in the entire gastric cancer group.

RESULTS:

Our study showed levels of NLR were significantly higher in gastric cancer cohort (2.17 (1.63-3.09) versus 1.62 (0.85-2.32), p< 0.001). After all the known confounders were excluded, NLR was an independent predicator of GC (OR = 1.446, 95%CI (1.121-1.866), and P= 0.005). Area under ROC curve (AUC) of NLR was 0.694. In addition, the results of Spearman's correlation showed NLR may have a positive correlation with size of tumor, N-stage, distant metastasis, and overall stage (r = 0.256, 0.256, 0.161 and 0.171, resp., all p < 0.05).

CONCLUSIONS:

The current study demonstrated that pre-treatment NLR may be a useful biomarker in the health care of gastric cancer patients.

Keywords: Gastric cancer, neutrophil lymphocyte ratio, routine blood examination, inflammation biomarker, retrospective study

Full Text

The Full Text of this article is available as a PDF (241.6 KB).

References

  • [1]. Anderson R., Tintinger G.R., Feldman C., Inflammation and cancer: The role of the human neutrophil, S. Afr. J. Sci., 110 (2014) 36-41. [Google Scholar]
  • [2]. Ardi V.C., Kupriyanova T.A., Deryugina E.I., Quigley J.P., Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis, Proc. Natl. Acad. Sci. U.S.A., 104 (2007) 20262-20267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [3]. Balkwill F., Mantovani A., Inflammation and cancer: back to Virchow? The Lancet, 357 (2001) 539-545. [DOI] [PubMed] [Google Scholar]
  • [4]. Chen Z., Xu W.R., Qian H., Zhu W., Bu X.F., Wang S., Yan Y.M., Mao F., Gu H.B., Cao H.L., Xu X.J., Oct4, a novel marker for human gastric cancer, J Surg Oncol, 99 (2009) 414-419. [DOI] [PubMed] [Google Scholar]
  • [5]. Chung H.W., Lim J.B., Role of the tumor microenvironment in the pathogenesis of gastric carcinoma, World journal of gastroenterology: WJG, 20 (2014) 1667-1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6]. De Larco J.E., Wuertz B.R., Furcht L.T., The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8, Clinical cancer research: an official journal of the American Association for Cancer Research, 10 (2004) 4895-4900. [DOI] [PubMed] [Google Scholar]
  • [7]. Deng Q., He B., Liu X., Yue J., Ying H., Pan Y., Sun H., Chen J., Wang F., Gao T., Zhang L., Wang S., Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model, Journal of translational medicine, 13 (2015) 66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8]. Ernst P., Review article: the role of inflammation in the pathogenesis of gastric cancer, Alimentary pharmacology & therapeutics, 13 Suppl 1 (1999) 13-18. [DOI] [PubMed] [Google Scholar]
  • [9]. Feng J.F., Huang Y., Chen Q.X., Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma, World journal of surgical oncology, 12 (2014) 58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10]. Hirohisa K., Yasuhiko K., Michiyo K., Songde C., Tsuyoshi K., Masanori I., Shinji T., Yasukazu O., Kazuaki C., Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma, Anticancer Research, 25 (2005). [PubMed] [Google Scholar]
  • [11]. Hundahl S.A., Phillips J.L., Menck H.R., The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the ``different disease'' hypothesis, Cancer, 88 (2000) 921-932. [PubMed] [Google Scholar]
  • [12]. Ilhan N., Ilhan N., Ilhan Y., Akbulut H., Kucuksu M., C-reactive protein, procalcitonin, interleukin-6, vascular endothelial growth factor and oxidative metabolites in diagnosis of infection and staging in patients with gastric cancer, World J. Gastroenterol., 10 (2004) 1115-1120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13]. Kawaguchi M., Akagi M., Gray M.J., Liu W.B., Fan F., Ellis L.M., Regulation of vascular endothelial growth factor expression in human gastric cancer cells by interleukin-1 beta, Surgery, 136 (2004) 686-692. [DOI] [PubMed] [Google Scholar]
  • [14]. Kilincalp S., Coban S., Akinci H., Hamamci M., Karaahmet F., Coskun Y., Ustun Y., Simsek Z., Erarslan E., Yuksel I., Neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as potential biomarkers for early detection and monitoring of colorectal adenocarcinoma, Eur. J. Cancer Prev., 24 (2015) 328-333. [DOI] [PubMed] [Google Scholar]
  • [15]. Kim D.K., Oh S.Y., Kwon H.C., Lee S., Kwon K.A., Kim B.G., Kim S.G., Kim S.H., Jang J.S., Kim M.C., Kim K.H., Han J.Y., Kim H.J., Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer, BMC cancer, 9 (2009) 155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16]. Koh C.H., Bhoo-Pathy N., Ng K.L., Jabir R.S., Tan G.H., See M.H., Jamaris S., Taib N.A., Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer, Br. J. Cancer, 113 (2015) 150-158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17]. Kubota H., Kotoh T., Masunaga R., Dhar D.K., Shibakita M., Tachibana M., Kohno H., Nagasue N., Impact of screening survey of gastric cancer on clinicopathological features and survival: retrospective study at a single institution, Surgery, 128 (2000) 41-47. [DOI] [PubMed] [Google Scholar]
  • [18]. Lee K., Hwang H., Nam K.T., Immune response and the tumor microenvironment: How they communicate to regulate gastric cancer, Gut and liver, 8 (2014) 131-139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19]. Lim J.B., Chung H.W., Serum ENA78/CXCL5, SDF-1/ CXCL12, and their combinations as potential biomarkers for prediction of the presence and distant metastasis of primary gastric cancer, Cytokine, 73 (2015) 16-22. [DOI] [PubMed] [Google Scholar]
  • [20]. Loureiro R.M., D'Amore P.A., Transcriptional regulation of vascular endothelial growth factor in cancer, Cytokine & growth factor reviews, 16 (2005) 77-89. [DOI] [PubMed] [Google Scholar]
  • [21]. Müller I., Munder M., Kropf P., Hänsch G.M., Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends in Immunology, 30 (2009) 522-530. [DOI] [PubMed] [Google Scholar]
  • [22]. Mantovani A., Cassatella M.A., Costantini C., Jaillon S., Neutrophils in the activation and regulation of innate and adaptive immunity, Nature reviews. Immunology, 11 (2011) 519-531. [DOI] [PubMed] [Google Scholar]
  • [23]. Milot E., Filep J.G., Regulation of neutrophil survival/ apoptosis by Mcl-1, The Scientific World Journal, 11 (2011) 1948-1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24]. Posul E., Yilmaz B., Aktas G., Kurt M., Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis? Wiener klinische Wochenschrift, 127 (2015) 262-265. [DOI] [PubMed] [Google Scholar]
  • [25]. Racz J.M., Cleghorn M.C., Jimenez M.C., Atenafu E.G., Jackson T.D., Okrainec A., Raghavan L.V., Quereshy F.A., Predictive Ability of Blood Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Gastrointestinal Stromal Tumors, Ann. Surg. Oncol., 22 (2015) 2343-2350. [DOI] [PubMed] [Google Scholar]
  • [26]. Smyth M.J., Dunn G.P., Schreiber R.D., Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity, Advances in immunology, 90 (2006) 1-50. [DOI] [PubMed] [Google Scholar]
  • [27]. Spolverato G., Maqsood H., Kim Y., Margonis G.A., Luo T., Ejaz A., Pawlik T.M., Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratio in Patients After Resection for Hepato-Pancreatico-Biliary Malignancies, J. Surg. Oncol., 111 (2015) 868-874. [DOI] [PubMed] [Google Scholar]
  • [28]. Tecchio C., Scapini P., Pizzolo G., Cassatella M.A., On the cytokines produced by human neutrophils in tumors, Seminars in cancer biology, 23 (2013) 159-170. [DOI] [PubMed] [Google Scholar]
  • [29]. Ulich T.R., del Castillo J., Guo K., Souza L., The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation, The American journal of pathology, 134 (1989) 149-159. [PMC free article] [PubMed] [Google Scholar]
  • [30]. Ulich T.R., del Castillo J., Guo K.Z., In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs, Blood, 73 (1989) 108-110. [PubMed] [Google Scholar]
  • [31]. Ulich T.R., del Castillo J., Keys M., Granger G.A., Ni R.X., Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes, Journal of immunology (Baltimore, Md.: 1950), 139 (1987) 3406-3415. [PubMed] [Google Scholar]
  • [32]. Washington K., 7th Edition of the AJCC Cancer Staging Manual: Stomach, Ann. Surg. Oncol., 17 (2010) 3077-3079. [DOI] [PubMed] [Google Scholar]
  • [33]. Xin-Ji Z., Yong-Gang L., Xiao-Jun S., Xiao-Wu C., Dong Z., Da-Jian Z., The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: A meta-analysis, International journal of surgery, 21 (2015) 84-91. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Biomarkers: Section A of Disease Markers are provided here courtesy of SAGE Publications

RESOURCES